112 related articles for article (PubMed ID: 25902479)
21. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity.
Peske JD; Thompson ED; Gemta L; Baylis RA; Fu YX; Engelhard VH
Nat Commun; 2015 May; 6():7114. PubMed ID: 25968334
[TBL] [Abstract][Full Text] [Related]
22. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.
Hepworth MR; Fung TC; Masur SH; Kelsen JR; McConnell FM; Dubrot J; Withers DR; Hugues S; Farrar MA; Reith W; Eberl G; Baldassano RN; Laufer TM; Elson CO; Sonnenberg GF
Science; 2015 May; 348(6238):1031-5. PubMed ID: 25908663
[TBL] [Abstract][Full Text] [Related]
23. Reversal of natural killer cell exhaustion by TIM-3 blockade.
Gallois A; Silva I; Osman I; Bhardwaj N
Oncoimmunology; 2014 Dec; 3(12):e946365. PubMed ID: 25964857
[TBL] [Abstract][Full Text] [Related]
24. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
[TBL] [Abstract][Full Text] [Related]
25. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.
Gharagozloo M; Kalantari H; Rezaei A; Maracy MR; Salehi M; Bahador A; Hassannejad N; Narimani M; Sanei MH; Bayat B; Ghazanfari H
Bratisl Lek Listy; 2015; 116(5):296-301. PubMed ID: 25924638
[TBL] [Abstract][Full Text] [Related]
26. Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.
Lagrue K; Carisey A; Morgan DJ; Chopra R; Davis DM
Blood; 2015 Jul; 126(1):50-60. PubMed ID: 26002964
[TBL] [Abstract][Full Text] [Related]
27. Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.
Michaud HA; Eliaou JF; Lafont V; Bonnefoy N; Gros L
Oncoimmunology; 2014 Oct; 3(9):e955684. PubMed ID: 25941618
[TBL] [Abstract][Full Text] [Related]
28. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.
Carretero R; Sektioglu IM; Garbi N; Salgado OC; Beckhove P; Hämmerling GJ
Nat Immunol; 2015 Jun; 16(6):609-17. PubMed ID: 25915731
[TBL] [Abstract][Full Text] [Related]
29. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
[TBL] [Abstract][Full Text] [Related]
30. Novel molecular mechanism for generating NK-cell fitness and memory.
Karo JM; Sun JC
Eur J Immunol; 2015 Jul; 45(7):1906-15. PubMed ID: 26018782
[TBL] [Abstract][Full Text] [Related]
31. Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21.
Li X; He C; Liu C; Ma J; Ma P; Cui H; Tao H; Gao B
Int J Oncol; 2015 Jul; 47(1):335-42. PubMed ID: 25975533
[TBL] [Abstract][Full Text] [Related]
32. Role natural killer group 2D-ligand interactions in hepatitis B infection.
Pollicino T; Koumbi L
World J Hepatol; 2015 Apr; 7(6):819-24. PubMed ID: 25937859
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Giannattasio A; Weil S; Kloess S; Ansari N; Stelzer EH; Cerwenka A; Steinle A; Koehl U; Koch J
BMC Cancer; 2015 May; 15():351. PubMed ID: 25933805
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy: The path to win the war on cancer?
Topalian SL; Wolchok JD; Chan TA; Mellman I; Palucka K; Banchereau J; Rosenberg SA; Dane Wittrup K
Cell; 2015 Apr; 161(2):185-6. PubMed ID: 26042237
[No Abstract] [Full Text] [Related]
35. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β.
Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS
Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178
[TBL] [Abstract][Full Text] [Related]
36. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α.
Mascanfroni ID; Takenaka MC; Yeste A; Patel B; Wu Y; Kenison JE; Siddiqui S; Basso AS; Otterbein LE; Pardoll DM; Pan F; Priel A; Clish CB; Robson SC; Quintana FJ
Nat Med; 2015 Jun; 21(6):638-46. PubMed ID: 26005855
[TBL] [Abstract][Full Text] [Related]
37. MET is required for the recruitment of anti-tumoural neutrophils.
Finisguerra V; Di Conza G; Di Matteo M; Serneels J; Costa S; Thompson AA; Wauters E; Walmsley S; Prenen H; Granot Z; Casazza A; Mazzone M
Nature; 2015 Jun; 522(7556):349-53. PubMed ID: 25985180
[TBL] [Abstract][Full Text] [Related]
38. Classifying Cancers Based on T-cell Infiltration and PD-L1.
Teng MW; Ngiow SF; Ribas A; Smyth MJ
Cancer Res; 2015 Jun; 75(11):2139-45. PubMed ID: 25977340
[TBL] [Abstract][Full Text] [Related]
39. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Spranger S; Bao R; Gajewski TF
Nature; 2015 Jul; 523(7559):231-5. PubMed ID: 25970248
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
Sato Y; Shimizu K; Shinga J; Hidaka M; Kawano F; Kakimi K; Yamasaki S; Asakura M; Fujii SI
Oncoimmunology; 2015 Mar; 4(3):e995541. PubMed ID: 25949922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
